Accelerated Phase (ap) - Cancer Science

Relevant Publications

HPLC with chiral stationary phase for separation and kinetics study of aspartic acid epimerization in Peroxiredoxin 2 active site peptide.

Issue Release: 2024

Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults.

Issue Release: 2024

Patient-reported outcomes in adults with tyrosine kinase inhibitor-resistant chronic myeloid leukemia receiving olverembatinib therapy.

Issue Release: 2024

Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations.

Issue Release: 2024

Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.

Issue Release: 2024

De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors.

Issue Release: 2024

Marine sponge-derived alkaloid inhibits the PI3K/AKT/mTOR signaling pathway against diffuse large B-cell lymphoma.

Issue Release: 2024

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era.

Issue Release: 2024

Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia.

Issue Release: 2024

Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors].

Issue Release: 2024

Chimeric antigen-receptor (CAR) engineered natural killer cells in a chronic myeloid leukemia (CML) blast crisis model.

Issue Release: 2024

Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN.

Issue Release: 2024

Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy.

Issue Release: 2024

Hsa_circ_0006010 and hsa_circ_0002903 in peripheral blood serve as novel diagnostic, surveillance and prognostic biomarkers for disease progression in chronic myeloid leukemia.

Issue Release: 2024

Chronic Myeloid Leukemia Unveils Its Dark Side: A Rare Case of Megakaryocytic Blast Crisis.

Issue Release: 2024

Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia.

Issue Release: 2024

HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosis.

Issue Release: 2024

Is there really an accelerated phase of chronic myeloid leukaemia at presentation?

Issue Release: 2024

High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.

Issue Release: 2023

Optimizing directional recovery of high-bioavailable phosphorus from human manure: Molecular-level understanding and assessment of application potential.

Issue Release: 2023

What Research is Being Conducted on Azacitidine?

How Do Cancer Nurses Stay Updated with Advances in Oncology?

How is Pediatric Cancer Diagnosed?

What are the Advantages of PCR in Cancer Research?

What Are the Challenges in Identifying Therapeutic Targets?

What are the benefits of using Excavator2 in Cancer Research?

What Challenges Exist in Cancer Monitoring and Identification?

How Does the Charity Support Cancer Research?

How is Allergic Contact Dermatitis Diagnosed in Cancer Patients?

Which Cancers Are Associated with Hyperinsulinemia?

Partnered Content Networks

Relevant Topics